FDA calendar · April 2021 · built from SEC filings

PDUFA dates April 2021: FDA calendar and catalysts.

Updated Snapshot 20261116T222116ZBuilt

0 PDUFA dates fell in April 2021. The FDA calendar also recorded 12 other catalysts that month, such as advisory committees and readouts, each quoted from the sponsor’s SEC filing or the FDA.

PDUFA dates in April 2021

No PDUFA dates are disclosed for this period as of November 16, 2026.

Download: CSV · JSON · iCal (next 30 days, CC BY 4.0) · Calendar API · All months

April 2021: other FDA decisions and filings

DateDrugCompanyEventIndicationStatusSource
April 1, 2021Praluent (alirocumab)REGNLabel expansion—ApprovedopenFDA Drugs@FDA
April 16, 2021Opdivo® (nivolumab)BMYLabel expansion—ApprovedopenFDA Drugs@FDA
April 19, 2021Diovan (valsartan)NVSLabel expansion—ApprovedopenFDA Drugs@FDA
April 22, 2021Jemperli (dostarlimab-gxly)GSKFDA approval—ApprovedopenFDA Drugs@FDA
April 23, 2021Zynlonta (loncastuximab tesirine-lpyl)ADCTFDA approval—ApprovedopenFDA Drugs@FDA
April 23, 2021Ingrezza Sprinkle (valbenazine tosylate)NBIXLabel expansion—ApprovedopenFDA Drugs@FDA
April 26, 2021Skyrizi (risankizumab-rzaa)ABBVLabel expansion—ApprovedopenFDA Drugs@FDA
April 29, 2021Daptomycin (daptomycin)BAXComplete Response Letter—CRL issuedFDA Complete Response Letters
April 29, 2021Morphine Sulfate (morphine sulfate)PFELabel expansion—ApprovedopenFDA Drugs@FDA
April 30, 2021Farxiga (dapagliflozin)AZNLabel expansion—ApprovedopenFDA Drugs@FDA
April 30, 2021Aubagio (teriflunomide)SNYLabel expansion—ApprovedopenFDA Drugs@FDA

April 2021: dated readouts

DateDrugCompanyEventIndicationStatusSource
Apr 2021Month disclosedISEMBYLD (apitegromab)SRRKTopline readout—PositiveSEC Form 10-Q

Questions

What PDUFA dates are in April 2021?

0 PDUFA dates fell in April 2021. The FDA calendar also recorded 12 other catalysts that month, such as advisory committees and readouts, each quoted from the sponsor’s SEC filing or the FDA.

Can these dates change?

Yes. The FDA can extend a review by three months after a major amendment, and it sometimes acts before the goal date. Each row links the filing the date came from.

Built from primary public sources only: sponsor SEC filings (8-K, EX-99.1, 10-Q, 10-K), the FDA advisory committee calendar, FDA Novel Drug Approvals and Complete Response Letter records, openFDA, and ClinicalTrials.gov (U.S. National Library of Medicine). Every row links the sentence it came from. Dates move; the linked source is authoritative. Not investment or medical advice.

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.